These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27146586)

  • 21. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
    Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
    JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.
    Yancik R; Wesley MN; Ries LA; Havlik RJ; Edwards BK; Yates JW
    JAMA; 2001 Feb; 285(7):885-92. PubMed ID: 11180731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trastuzumab-related cardiotoxicity among older patients with breast cancer.
    Chavez-MacGregor M; Zhang N; Buchholz TA; Zhang Y; Niu J; Elting L; Smith BD; Hortobagyi GN; Giordano SH
    J Clin Oncol; 2013 Nov; 31(33):4222-8. PubMed ID: 24127446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status.
    Farias AJ; Du XL
    Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1266-1275. PubMed ID: 28515111
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.
    Wolff AC; Blackford AL; Visvanathan K; Rugo HS; Moy B; Goldstein LJ; Stockerl-Goldstein K; Neumayer L; Langbaum TS; Theriault RL; Hughes ME; Weeks JC; Karp JE
    J Clin Oncol; 2015 Feb; 33(4):340-8. PubMed ID: 25534386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27.
    Chapman JA; Shepherd LE; Ingle JN; Muss HB; Pritchard KI; Gelmon KA; Whelan TJ; Elliott C; Goss PE
    Breast Cancer Res Treat; 2016 Apr; 156(2):343-9. PubMed ID: 27006189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a scientific presentation on community treatment patterns for primary breast cancer.
    Giordano SH; Duan Z; Kuo YF; Hortobagyi GN; Freeman J; Goodwin JS
    J Natl Cancer Inst; 2006 Mar; 98(6):382-8. PubMed ID: 16537830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis.
    Green SL; Dawe DE; Nugent Z; Cheung WY; Czaykowski PM
    J Geriatr Oncol; 2019 Jan; 10(1):132-137. PubMed ID: 30104156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapeutic decisions in elderly breast cancer patients: the role of chemotherapy in a retrospective analysis.
    Jueckstock J; Kasch F; Jaeger B; Schramm A; Janni W; Scholz C
    Arch Gynecol Obstet; 2015 Nov; 292(5):1101-7. PubMed ID: 25935195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Chan A; Delaloge S; Holmes FA; Moy B; Iwata H; Harvey VJ; Robert NJ; Silovski T; Gokmen E; von Minckwitz G; Ejlertsen B; Chia SKL; Mansi J; Barrios CH; Gnant M; Buyse M; Gore I; Smith J; Harker G; Masuda N; Petrakova K; Zotano AG; Iannotti N; Rodriguez G; Tassone P; Wong A; Bryce R; Ye Y; Yao B; Martin M;
    Lancet Oncol; 2016 Mar; 17(3):367-377. PubMed ID: 26874901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disparities in the Initial Local Treatment of Older Women with Early-Stage Breast Cancer: A Population-Based Study.
    LeMasters TJ; Madhavan SS; Sambamoorthi U; Vyas AM
    J Womens Health (Larchmt); 2017 Jul; 26(7):735-744. PubMed ID: 28170302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer.
    Shen X; Anne PR; Keith SW; Wojcieszynski A; Mishra MV; Bar-Ad V; Showalter TN
    Am J Clin Oncol; 2014 Jun; 37(3):241-7. PubMed ID: 23241502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant Chemotherapy for Breast Cancer in Older Women: An Analysis of Retrospective English Cancer Registration Data.
    Ward SE; Holmes GR; Ring A; Richards PD; Morgan JL; Broggio JW; Collins K; Reed MWR; Wyld L
    Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):444-452. PubMed ID: 31122807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.
    Raji MA; Tamborello LP; Kuo YF; Ju H; Freeman JL; Zhang DD; Giordano SH; Goodwin JS
    Med Oncol; 2009 Dec; 26(4):452-9. PubMed ID: 19067255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009.
    Yeboa DN; Xu X; Jones BA; Soulos P; Gross C; Yu JB
    Am J Clin Oncol; 2016 Dec; 39(6):568-574. PubMed ID: 24879475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceptance of adjuvant chemotherapy recommendations in early-stage hormone-positive breast cancer.
    Marcinkowski EF; Ottesen R; Niland J; Vito C
    J Surg Res; 2017 Jun; 214():79-85. PubMed ID: 28624063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
    J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.
    Chen J; Wu X; Christos PJ; Formenti S; Nagar H
    Breast Cancer Res; 2018 Apr; 20(1):26. PubMed ID: 29661221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.